alexa Gut Microbiota: What We Could Do, Not Just Use ‘Young Healthy Poo’ for Drugs? | Open Access Journals
ISSN: 2376-0419
Journal of Pharmaceutical Care & Health Systems
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Gut Microbiota: What We Could Do, Not Just Use ‘Young Healthy Poo’ for Drugs?

Yiqing Y*

School of Life Science, University of Science and Technology of China, Hefei, Anhui, 230027, China

*Corresponding Author:
Yiqing Y
School of Life Science
University of Science and Technology of China
Hefei, Anhui, 230027, China
Tel: +0551-63600130
E-mail: [email protected]

Received Date: April 18, 2017; Accepted Date: April 22, 2017; Published Date: April 28, 2017

Citation: Yiqing Y (2017) Gut Microbiota: What We Could Do, Not Just Use ‘Young Healthy Poo’ for Drugs?. J Pharma Care Health Sys 4:173. doi: 10.4172/2376-0419.1000173

Copyright: © 2017 Yiqing Y. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Pharmaceutical Care & Health Systems

Introduction

The faeces were used as ‘drugs’ for years. If patients occasionally have taken overdose antibiotics, doctors just give them faeces from whom they live with to help rebuilt their gut microbiomes. As the technologies developed, we know gut microbiomes have changed if being obesity [1], being sick [2] or being ageing [3], so researchers tried to make faeces ‘drugs’ from thin, healthy and young individuals [4]. It’s prospective and shows great benefits if this idea works in the near future, however, in this review, we’d like to discuss some other essential questions in this area.

Culture System

Gut microbes culture

From microscopical view, for now just parts of gut microbiomes could be cultured in vitro [5]. However, new culturing approaches, like microbial culturomics [6], were introduced recently and doubling the number of culturable species. As more and more experimental parameters could be modulated artificially and smoothly, more and more bacterias could become culturable in the near future. At least two areas could from get benefits this. One is drug or antibiotics developments. For instance, culturable B. adolescentis is helpful in drug development targeting Th17 cells [7]. The other one is improving the in vitro bacteria-host cell model, which is more easily and tightly manipulated than in vivo animal models.

Mono-associated mice

Mice associated with a single or a limited number of bacterial species, or so called mono-associated mouse model, have been used for decades [8,9]. This model has previously been developed to define the taxonomy and functions of a single bacteria, but for now it is also an crucial tool to analyze the microbiota-host relationships in the gut. Geva-Zatorsky and his colleagues have recently showed a comprehensive immunomodulatory role of gut microbiota using selected 53 different mono-associated mice and observed a bunch of uncharacterized bacteria-host interactions [10]. The next step might be focusing on this two aspects: one is what is the molecular mechanisms when a certain bacteria was introduced to mice, and the other is why these immune responses happens and what happens after the initial immune response.

Gut resident cells

Except for microbiomes, there are also various kinds of cells residing in the gut, like neurons in the nervous system [11] and lymphocytes and myeloid cells in the immune system [12,13]. Most of these primary cells or cell lines could be isolated and cultured in monolayers, and it would be a simplified bacteria-host system if supplied with bacterias. However it is far from enough, Yissachar et al. recently built an organ culture system using the mouse intestine, which might try the best to keep hosts’ components complete and alive, and also make some essential factors controllable [14]. Of note, mouse intestines from different disease models could also be used as the culture systems, which much broadens this system’s applications.

Cross Talks

From macroscopical view, gut microbiota might also be regarded as an indivisible whole, and tightly coordinated with immune system, metabolic system and nervous system, which might take at least three more reviews to discuss. Very recently, Lefrançais et al. showed that the megakaryocytic cells circulated in the lung and produced approximately half of the total platelet using 2-photon intravital microscopy [15], which leads us to look back forward to think over some fundamental questions, from the origins of fetus microbiota, the evolutions, the changes to the regulations of adult microbiota.

Increasing evidences suggest that gut microbiota have already been set up before birth [16], but still some gaps left. First, at which period of pregnancy the microbiota is seeded? Second, is the proces that bacterias get through maternal-fetal interface selectively or unselectively and what is the regulative networks? Third, does the fetus’s immune system and nervous system coevolve with microbiota and how?

Certain bacterial species could promote or induce certain immune cells. For example, Th17 cells accumulate in the gut and take its role as the safeguards there by secreting cytokines like IL-17 and IL-22, and inducing some antimicrobial peptides and tight junction proteins from intestinal epithelial cells [17-19]. Both segmented filamentous bacteria (SFB) from mice’s gut [20-22] and B. adolescentis from human’ [23] could induce T Helper 17 cells (Th17). Not surprisingly, gut microbiota-derived products, such as short-chain fatty acids (SCFAs), adenosine triphosphate (ATP) and various cytokines could also regulate the immune cells and immune response directly or indirectly [23]. For instance, excessive production and accumulation of SCFAs such as acetic acid, propionic acid and butyric acid, cause the increased luminal carbohydrates malabsorption and poor gastrointestinal motility, and ultimately might lead to the necrotizing enterocolitis, especially premature infants, whose immune systems are not fully established. Various immune cells are involved in this process and most of them have receptors for SCFAs, but which is particularly responsible for this is poorly discussed. On the other hand, IgA is the crucial host immune effector to modulate microbiota back [23]. However, we know much less about how certain immune cells control or regulate gut microbiota, by phagorytosis or by secreted cytokines or something else? Moreover, it is still lack of whole pictures that the gut microbiota triggers comprehensive immune responses while the immune systems trim gut microbiota as a feedback.

To sum up, the research on microbiota has dramatically advanced these years, but still numerous issues need to be elucidated. One aspect is to further improve the technologies, and the other is some basal questions to be proposed and clarified, from molecular, signaling pathway to organ levels.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Recommended Conferences

Article Usage

  • Total views: 344
  • [From(publication date):
    April-2017 - Oct 19, 2017]
  • Breakdown by view type
  • HTML page views : 306
  • PDF downloads :38
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords